Havemeyer Place LP Buys New Position in HCA Healthcare, Inc. $HCA

Havemeyer Place LP bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 1,880 shares of the company’s stock, valued at approximately $878,000.

A number of other large investors also recently modified their holdings of HCA. Capital World Investors lifted its stake in shares of HCA Healthcare by 3.8% in the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after buying an additional 179,443 shares in the last quarter. Geode Capital Management LLC increased its holdings in HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $1,262,513,000. Arrowstreet Capital Limited Partnership boosted its holdings in HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after acquiring an additional 36,414 shares during the last quarter. Finally, Viking Global Investors LP lifted its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 3.0%

HCA opened at $360.99 on Tuesday. The company has a 50 day moving average of $437.12 and a 200 day moving average of $476.37. The company has a market cap of $80.08 billion, a PE ratio of 12.41, a price-to-earnings-growth ratio of 1.18 and a beta of 1.12. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on HCA shares. Robert W. Baird cut their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Sanford C. Bernstein cut their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research report on Thursday. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Finally, Stephens reduced their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.